Available Technologies

Find technologies available for licensing from UCSF.

No technologies match these criteria.
Schedule UC TechAlerts to receive an email when technologies are published that match this search. Click on the Save Search link above

Results/page

Novel Anti-HLA-Pan-DP CAR-T cells for Targeted Cancer Immunotherapy

Brief description not available

Targeted Immunotherapy for Multiple Myeloma: Novel Mutant CCL27 Binders Targeting CCR10

Brief description not available

Safety Strategies For Hypoimmune Cells

Brief description not available

Precision In Vivo Gene Editing Using Dual-Vector Delivery Systems

Brief description not available

Combination Therapy For CNS Lymphoma

Brief description not available

Myeloid Differentiation Factor-Expressing Retroviral Vector for Tumor Therapy

Brief description not available

Antibody-Based Chemically Induced Dimerizers (AbCIDs)

This novel technology enables refined temporal control of protein-protein interactions that can be used to regulate cell therapies, including CAR T-cells and “cell factories”.

Novel CAR-T Therapy for Glioblastoma

Brief description not available